Lawitz, Eric <br/><br/>
Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST-2).  [electronic resource] 

 -  Hepatology (Baltimore, Md.)  08 2016 
 - 360-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-3350 
<br/><br/><label>Standard No.: </label>10.1002/hep.28422  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antiviral Agents--therapeutic use<br/>Drug Therapy, Combination<br/>Female<br/>Hepacivirus--genetics<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Simeprevir--therapeutic use<br/>Sofosbuvir--therapeutic use<br/>Treatment Outcome